| 2025-11-06 |
详情>>
股本变动：
变动后总股本986.56万股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.44美元,归母净利润-560.44万美元,同比去年增长26.96%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘后发布财报
|
| 2025-09-30 |
复牌提示：
2025-09-29 13:00:18 停牌，复牌日期 2025-09-29 13:05:18
|
| 2025-08-01 |
详情>>
内部人交易：
Markovits Joel等共交易4笔
|
| 2025-07-30 |
详情>>
业绩披露：
2025年中报每股收益-1.53美元,归母净利润-444.78万美元,同比去年增长34.94%
|
| 2025-05-14 |
详情>>
业绩披露：
2025年一季报每股收益-0.66美元,归母净利润-173.69万美元,同比去年增长67.51%
|
| 2025-04-15 |
股东大会：
将于2025-05-29召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees for director named herein to our Board of Directors, each to serve a one-year term expiring at the 2026 Annual Meeting of Stockholders and until such director’s successor is duly elected and qualified;
2.To approve the 2025 Equity Incentive Plan;
3.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this Proxy Statement;
4.To ratify the appointment of Urish Popeck & Co., LLC as our independent registered public accounting firm for our fiscal year ending on December 31, 2025;
5.To transact such other business as may properly come before the 2025 Annual Meeting or any adjournments or postponements of the 2025 Annual Meeting.
|
| 2025-03-07 |
详情>>
业绩披露：
2024年年报每股收益-9.01美元,归母净利润-907.16万美元,同比去年增长24.47%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-10.56美元,归母净利润-767.34万美元,同比去年增长-157.25%
|
| 2024-10-31 |
股东大会：
将于2024-12-16召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees for director named herein to our Board of Directors, each to serve a one-year term expiring at the 2025 Annual Meeting of Stockholders and until such director’s successor is duly elected and qualified;
2.To approve the 2024 Omnibus Incentive Plan;
3.To approve the amendment of the Articles of Incorporation, as amended, to increase the total number of authorized shares of our common stock, $0.086 par value per share, from 117,647,058 shares to 2,000,000,000 shares;
4.To ratify the appointment of Urish Popeck & Co., LLC as our independent registered public accounting firm for our fiscal year ending on December 31, 2024;
5.To transact such other business as may properly come before the 2024 Annual Meeting or any adjournments or postponements of the 2024 Annual Meeting.
|
| 2024-07-25 |
详情>>
业绩披露：
2024年中报每股收益-14.77美元,归母净利润-683.61万美元,同比去年增长-140.38%
|
| 2024-07-01 |
详情>>
拆分方案：
每17.0000合并分成1.0000股
|
| 2024-05-20 |
详情>>
业绩披露：
2024年一季报每股收益-0.81美元,归母净利润-534.67万美元,同比去年增长-198.94%
|
| 2024-04-04 |
详情>>
业绩披露：
2023年年报每股收益-5.16美元,归母净利润-1201万美元,同比去年增长-285.74%
|
| 2024-01-30 |
股东大会：
将于2024-03-13召开股东大会
会议内容 ▼▲
- 1.To approve the potential issuance of shares of the Company’s common stock in excess of 19.99% of our outstanding common stock pursuant to Nasdaq listing rules;
2.To approve the 2024 Equity Incentive Plan;
3.To transact such other business as may properly come before the Special Meeting or any adjournments or postponements of the Special Meeting.
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.22美元,归母净利润-298.28万美元,同比去年增长-111.49%
|
| 2023-10-04 |
股东大会：
将于2023-11-14召开股东大会
会议内容 ▼▲
- 1.To amend the Warrant Agent Agreement, dated February 8, 2021, by and between the Company and VStock Transfer, LLC (the “Warrant Agreement”), pursuant to which the Series A Warrants were issued, in order to reduce the exercise price of the Series A Warrants issued and outstanding under the Warrant Agreement from the stated $6.60 (post-reverse split effective exercise price of $99.00) per share to $6.13 per share, subject to adjustment (the “Exercise Price Adjustment Proposal”);
2.To consider and vote upon a proposal to adjourn the Series A Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Series A Meeting, we are not authorized to consummate the Exercise Price Adjustment Proposal (the “Series A Adjournment Proposal”).
|
| 2023-10-04 |
股东大会：
将于2023-11-14召开股东大会
会议内容 ▼▲
- 1.To elect the five nominees for director named herein to our Board of Directors, each to serve a one-year term expiring at the 2024 Annual Meeting of Stockholders and until such director’s successor is duly elected and qualified;
2.To approve the amendment of the Articles of Incorporation, as amended, to increase the total number of authorized shares of our common stock, $0.086 par value per share, from 133,333,333 shares to 2,000,000,000;
3.To approve the 2023 Equity Incentive Plan
4.To transact such other business as may properly come before the 2023 Annual Stockholder Meeting or any adjournments or postponements of the 2023 Annual Stockholder Meeting.
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-1.33美元,归母净利润-284.38万美元,同比去年增长-114.34%
|
| 2023-02-23 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2022-09-21 |
股东大会：
将于2022-10-27召开股东大会
会议内容 ▼▲
- 1.To elect the five (5) nominees for director named herein to our Board of Directors, each to serve a one-year term expiring at the 2023 Annual Meeting of Stockholders and until such director’s successor is duly elected and qualified;
2.To ratify the appointment of Mazars USA LLP as our independent registered public accounting firm for our fiscal year ending on December 31, 2022;
3.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement;
4.To recommend, on an advisory basis, a three-year frequency for holding an advisory vote on executive compensation;
5.To transact such other business as may properly come before the 2022 Annual Meeting or any adjournments or postponements of the 2022 Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|